R. Becker

发表

The Risk of Interrupting Long‐Term Anticoagulant Treatment: A Rebound Hypercoagulable State Following Hemorrhage

C. Moschos, H. Sise, J. Gauthier, 1961, Circulation.

Relation of hemorrhage and thrombosis to prothrombin during treatment with coumarin-type anticoagulants.

D. Adamis, H. Sise, S. Lavelle, 1958, The New England journal of medicine.

On the nature of hypercoagulability.

C. Moschos, H. Sise, R. Becker, 1962, The American journal of medicine.

Sulfonylureas and sulfonylcarbamates as new non-tetrazole angiotensin II receptor antagonists. Discovery of a highly potent orally active (imidazolylbiphenylyl)sulfonylurea (HR 720).

H. Heitsch, M. Fortin, G. Hamon, 1995, Journal of medicinal chemistry.

4,5-Dihydro-3-(methanesulfonamidophenyl)-1-phenyl-1H-2,4-benzodiazepines: a novel class III antiarrhythmic agents.

G. M. Briggs, G M Briggs, R. E. Johnson, 1995, Journal of medicinal chemistry.

Bis basic substituted diaminobenzobisthiazoles as potential antiarthritic agents.

H. Wong, E. Cullen, R. Becker, 1992, Journal of medicinal chemistry.

Blood coagulation factors in total body irradiation.

H. Sise, J. Gauthier, R. Becker, 1961, Blood.

Pharmacokinetics of Tramadol and Bioavailability of Enteral Tramadol Formulations 4th Communication: Drops (without ethanol)

R. Becker, J. Gerloff, R. Terlinden, 2000, Arzneimittelforschung.

Spontaneous circulating anticoagulant (antifactor VIII).

J. Desforges, H. Sise, J. Gauthier, 1962, The American journal of medicine.